School of Medicine

Anthony Charles, MD, MPH

Malawi Surgical Initiative Leader on the Unintended Consequences of Centralized Blood Banking

January 23, 2017

In the late 1990s, the World Health Organization (WHO) issued a policy requiring the establishment of centralized blood banking facilities in Sub-Saharan African countries. Anthony Charles, an associate professor of surgery at the University of North Carolina at Chapel Hill School of Medicine, says that this policy is now having unintended negative consequences. In a commentary… Read more »

Can Nanotechnology Help Develop a Workable Dengue Virus Vaccine?

November 18, 2016

Scientists at the University of North Carolina at Chapel Hill School of Medicine are working to develop a nanoparticle vaccine to protect against the four serotypes of dengue virus, which infects more than 350 million people across the globe each year. Aravinda de Silva, professor of microbiology and immunology, and post-doctoral researcher Stefan Metz recently published… Read more »

Taking Care of the Small Stuff

August 3, 2016

As a kid growing up in Ethiopia, Tigist Tamir was interested in how things work. She recalls being a “ridiculous kid” who would break things around the house just to see if she could put them back together. “It was always like that,” she remembers. “There were lots of kids who would gather items and… Read more »

Anthony Charles Trains a Country’s Surgeons

August 2, 2016

By formal training, Anthony Charles is a trauma surgeon. By experience, he’s a diplomat. Charles leads the Malawian Surgical Initiative, a partnership between the University of North Carolina at Chapel Hill Department of Surgery, Kamuzu Central Hospital in Lilongwe, Malawi, and the Malawi College of Medicine in Blantyre, Malawi. On December 5, 2015, the first… Read more »

Fischer to Serve as Co-PI of Ebola Trial in Liberia

July 15, 2016

The Partnership for Research on Ebola Virus in Liberia (PREVAIL), a U.S.-Liberia joint cinical research partnership, on July 5 announced the opening of PREVAIL IV, a treatment trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola virus genetic material, RNA, in their semen. The trial is sponsored… Read more »

De Silva Leads Expert Panel on Zika Research, Response

June 9, 2016

The Zika virus isn’t unprecedented, epidemiologically speaking. What is unprecedented, however, is its associated birth defects, including microcephaly, as well as the fact that it can be sexually transmitted. That’s according to Aravinda de Silva, professor of microbiology and immunology at the University of North Carolina at Chapel Hill School of Medicine, who was part of… Read more »